BG MEDICAL: what changed
BG MEDICAL
Largest movements
- Tangible fixed assets +€87,761
new in 2025: €87,761
of which Assets under construction and advance payments: +€79,487
- Cash -€10,520
down €10,520 (-30.8%), from €34,144 to €23,624
mainly Investment in fixed assets (net) (-€103,989) and Receivables within one year (-€3,540)
- Receivables within one year +€3,540
up €3,540 (+31.8%), from €11,140 to €14,680
of which Other amounts receivable: +€1,818
- Deferred charges and accrued income +€1,888
up €1,888 (+92.7%), from €2,036 to €3,924
- Profit (loss) carried forward +€33,487
up €33,487 (+285%), from €11,738 to €45,225
- Debts after one year +€29,513
new in 2025: €29,513
- Reserves +€15,000
up €15,000 (+100%), from €15,000 to €30,000
- Tax, wage and social debts +€5,395
up €5,395 (+35.5%), from €15,189 to €20,584
- Gross operating margin +€42,717
up €42,717 (+96.7%), from €44,153 to €86,870
- Depreciation +€14,605
up €14,605 (+900%), from €1,623 to €16,228
- Taxes +€5,618
up €5,618 (+45.7%), from €12,290 to €17,908
- Financial charges +€1,601
up €1,601 (+78.0%), from €2,052 to €3,653
- Other operating charges -€884
down €884 (-59.8%), from €1,478 to €594
Change in the result, 2024 to 2025
For each income-statement line you see the change as its effect on the result. Higher costs lower the result, higher income raises it.
Derived cash bridge
The bridge is derived from the 2024 and 2025 balance sheets and the 2025 result. There is no filed cash-flow statement. You see where the money came from and where it went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €47,320 | €129,989 | +€82,669 | +175% |
| Fixed assets | 21/28 | - | €87,761 | +€87,761 | |
| Tangible fixed assets | 22/27 | - | €87,761 | +€87,761 | |
| Furniture and vehicles | 24 | - | €8,274 | +€8,274 | |
| Assets under construction and advance payments | 27 | - | €79,487 | +€79,487 | |
| Current assets | 29/58 | €47,320 | €42,228 | -€5,092 | -10.8% |
| Amounts receivable within one year | 40/41 | €11,140 | €14,680 | +€3,540 | +31.8% |
| Trade receivables | 40 | - | €1,722 | +€1,722 | |
| Other amounts receivable | 41 | €11,140 | €12,958 | +€1,818 | +16.3% |
| Cash at bank and in hand | 54/58 | €34,144 | €23,624 | -€10,520 | -30.8% |
| Deferred charges and accrued income | 490/1 | €2,036 | €3,924 | +€1,888 | +92.7% |
| Total equity and liabilities | 10/49 | €47,320 | €129,989 | +€82,669 | +175% |
| Equity | 10/15 | €30,738 | €79,225 | +€48,487 | +158% |
| Contributions | 10/11 | €4,000 | €4,000 | = | 0.0% |
| Reserves | 13 | €15,000 | €30,000 | +€15,000 | +100% |
| Distributable reserves | 133 | €15,000 | €30,000 | +€15,000 | +100% |
| Profit (loss) carried forward | 14 | €11,738 | €45,225 | +€33,487 | +285% |
| Amounts payable | 17/49 | €16,582 | €50,764 | +€34,182 | +206% |
| Amounts payable after more than one year | 17 | - | €29,513 | +€29,513 | |
| Financial debts | 170/4 | - | €29,513 | +€29,513 | |
| Amounts payable within one year | 42/48 | €16,582 | €21,251 | +€4,669 | +28.2% |
| Trade debts | 44 | €126 | €667 | +€541 | +429% |
| Suppliers | 440/4 | €126 | €667 | +€541 | +429% |
| Taxes, remuneration and social security | 45 | €15,189 | €20,584 | +€5,395 | +35.5% |
| Taxes | 450/3 | €15,189 | €20,584 | +€5,395 | +35.5% |
| Other amounts payable | 47/48 | €1,267 | - | -€1,267 | |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €1,623 | €16,228 | +€14,605 | +900% |
| Other operating charges | 640/8 | €1,478 | €594 | -€884 | -59.8% |
| Gross operating margin | 9900 | €44,153 | €86,870 | +€42,717 | +96.7% |
| Operating profit (loss) | 9901 | €41,052 | €70,048 | +€28,996 | +70.6% |
| Financial income | 75/76B | €28 | - | -€28 | |
| Recurring financial income | 75 | €28 | - | -€28 | |
| Financial charges | 65/66B | €2,052 | €3,653 | +€1,601 | +78.0% |
| Recurring financial charges | 65 | €2,052 | €3,653 | +€1,601 | +78.0% |
| Profit (loss) for the period before taxes | 9903 | €39,028 | €66,395 | +€27,367 | +70.1% |
| Income taxes | 67/77 | €12,290 | €17,908 | +€5,618 | +45.7% |
| Profit (loss) for the period | 9904 | €26,738 | €48,487 | +€21,749 | +81.3% |
| Profit (loss) for the period to be appropriated | 9905 | €26,738 | €48,487 | +€21,749 | +81.3% |
Next steps
Calculation and sources
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Green is a favourable move for that line, red an unfavourable one. Prepared on 2 November 2026 via checked.be.